188 related articles for article (PubMed ID: 37069746)
1. MicroRNA-147b induces neuroendocrine differentiation of prostate cancer cells by targeting ribosomal protein RPS15A.
Natani S; Ramakrishna M; Nallavolu T; Ummanni R
Prostate; 2023 Jul; 83(10):936-949. PubMed ID: 37069746
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-147b suppresses the proliferation and invasion of non-small-cell lung cancer cells through downregulation of Wnt/β-catenin signalling via targeting of RPS15A.
Ning Q; Pang Y; Shao S; Luo M; Zhao L; Hu T; Zhao X
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):449-458. PubMed ID: 31665807
[TBL] [Abstract][Full Text] [Related]
3. Long Non-coding RNA AFAP1-AS1 Facilitates Prostate Cancer Progression by Regulating miR-15b/IGF1R Axis.
Liu B; Jiang HY; Yuan T; Zhou WD; Xiang ZD; Jiang QQ; Wu DL
Curr Pharm Des; 2021; 27(41):4261-4269. PubMed ID: 34126893
[TBL] [Abstract][Full Text] [Related]
4. Tumor protein D52 (isoform 3) induces NF-κB - STAT3 mediated EMT driving neuroendocrine differentiation of prostate cancer cells.
Sruthi KK; Natani S; Ummanni R
Int J Biochem Cell Biol; 2024 Jan; 166():106493. PubMed ID: 37935328
[TBL] [Abstract][Full Text] [Related]
5. Activation of TGF-β - SMAD2 signaling by IL-6 drives neuroendocrine differentiation of prostate cancer through p38MAPK.
Natani S; Sruthi KK; Asha SM; Khilar P; Lakshmi PSV; Ummanni R
Cell Signal; 2022 Mar; 91():110240. PubMed ID: 34986386
[TBL] [Abstract][Full Text] [Related]
6. AMPK/SIRT1 signaling through p38MAPK mediates Interleukin-6 induced neuroendocrine differentiation of LNCaP prostate cancer cells.
Natani S; Dhople VM; Parveen A; Sruthi KK; Khilar P; Bhukya S; Ummanni R
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119085. PubMed ID: 34171447
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation.
Niture S; Tricoli L; Qi Q; Gadi S; Hayes K; Kumar D
Tumour Biol; 2022; 44(1):107-127. PubMed ID: 35811549
[TBL] [Abstract][Full Text] [Related]
8. MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.
Zheng C; Yinghao S; Li J
Med Oncol; 2012 Jun; 29(2):815-22. PubMed ID: 21487968
[TBL] [Abstract][Full Text] [Related]
9. Enzalutamide-Induced Upregulation of PCAT6 Promotes Prostate Cancer Neuroendocrine Differentiation by Regulating miR-326/HNRNPA2B1 Axis.
Liu B; Jiang HY; Yuan T; Luo J; Zhou WD; Jiang QQ; Wu D
Front Oncol; 2021; 11():650054. PubMed ID: 34277403
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of microRNA-519d-3p suppressed the growth of pancreatic cancer cells by inhibiting ribosomal protein S15A-mediated Wnt/β-catenin signaling.
Liang J; Liu Y; Zhang L; Tan J; Li E; Li F
Chem Biol Interact; 2019 May; 304():1-9. PubMed ID: 30831090
[TBL] [Abstract][Full Text] [Related]
11. The β
Braadland PR; Ramberg H; Grytli HH; Urbanucci A; Nielsen HK; Guldvik IJ; Engedal A; Ketola K; Wang W; Svindland A; Mills IG; Bjartell A; Taskén KA
Mol Cancer Res; 2019 Nov; 17(11):2154-2168. PubMed ID: 31395667
[TBL] [Abstract][Full Text] [Related]
12. Autophagy pathway is required for IL-6 induced neuroendocrine differentiation and chemoresistance of prostate cancer LNCaP cells.
Chang PC; Wang TY; Chang YT; Chu CY; Lee CL; Hsu HW; Zhou TA; Wu Z; Kim RH; Desai SJ; Liu S; Kung HJ
PLoS One; 2014; 9(2):e88556. PubMed ID: 24551118
[TBL] [Abstract][Full Text] [Related]
13. The deregulation of miR-17/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells.
Dankert JT; Wiesehöfer M; Czyrnik ED; Singer BB; von Ostau N; Wennemuth G
PLoS One; 2018; 13(7):e0200472. PubMed ID: 30001402
[TBL] [Abstract][Full Text] [Related]
14. A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells.
Ding M; Lin B; Li T; Liu Y; Li Y; Zhou X; Miao M; Gu J; Pan H; Yang F; Li T; Liu XY; Li R
Oncotarget; 2015 Apr; 6(10):7686-700. PubMed ID: 25797256
[TBL] [Abstract][Full Text] [Related]
15. miR-147b is an oncomiR acting synergistically with HIPK2 to promote pancreatic carcinogenesis.
Wang G; Ma Z; Song C; Wang X; Zhou Z
Cell Signal; 2023 Nov; 111():110840. PubMed ID: 37543099
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer.
Rönnau CGH; Fussek S; Smit FP; Aalders TW; van Hooij O; Pinto PMC; Burchardt M; Schalken JA; Verhaegh GW
World J Urol; 2021 Oct; 39(10):3789-3797. PubMed ID: 33990872
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of RE-1 silencing transcription factor (REST) in advanced prostate cancer by hypoxia-induced miR-106b~25.
Liang H; Studach L; Hullinger RL; Xie J; Andrisani OM
Exp Cell Res; 2014 Jan; 320(2):188-99. PubMed ID: 24135225
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast-derived exosomal microRNA regulates NKX3-1 expression in androgen-sensitive, androgen receptor-dependent prostate cancer cells.
Matsuda C; Ishii K; Nakagawa Y; Shirai T; Sasaki T; Hirokawa YS; Iguchi K; Watanabe M
J Cell Biochem; 2023 Aug; 124(8):1135-1144. PubMed ID: 37334663
[TBL] [Abstract][Full Text] [Related]
20. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
